CD44 and neoplasm: Taking into consideration that CD44 is a transcriptional target of Notch-1 [37], apparently downstream of Hes1/Hey1 [38], we concluded that β-elemene could attenuate tumor angiogenesis by targeting GCSCs at least in part through Notch-1 expression.